Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Mastodynon"'
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 107-111 (2022)
The article presents updated data concerning the molecular mechanisms of influence of the well-known in clinical practice drug Mastodynon. The paper provides evidence of a significant effect of the compounds containing in its composition on the cell
Externí odkaz:
https://doaj.org/article/095e95a07a834cb0808599102cfd78ea
Autor:
V. N. Prilepskaya, E. R. Dovletkhanova
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 106-115 (2020)
Premenstrual syndrome is a symptom complex characterized by repeated physical, psycho-emotional, behavioral symptoms that develop into the luteal phase of the cycle (2-14 days before menstruation) and disappear with its onset. The basis of the PMS di
Externí odkaz:
https://doaj.org/article/be6bbe19858142c7a444c80d3db7e1e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
А. Г. Кедрова, С. А. Леваков
Publikováno v:
Репродуктивная эндокринология, Vol 0, Iss 48, Pp 77-81 (2019)
Implementation of breast cancer screening using digital mammography improved the diagnosis of primary proliferative regressive structural changes in the breast, manifested as diffuse or diffusely-nodal deformations of tissues. Currently, women are si
Externí odkaz:
https://doaj.org/article/e5b27b001019425f8043aadc224a2f95
Autor:
N. V. Kulagina
Publikováno v:
Медицинский совет, Vol 0, Iss 6, Pp 136-140 (2019)
Research objective. To carry out the overview of the published works devoted to assessment of efficiency and safety of the phytodrug mastodynon, which includes Vitexagnus-castus extract, in treatment of mastalgia caused by a benign dysplasia of mamma
Externí odkaz:
https://doaj.org/article/71d82f4dd0a74015b5d20f2758b6f3ce
Autor:
Ю. Я. Присташ
Publikováno v:
Репродуктивная эндокринология, Iss 44, Pp 36-39 (2018)
The purpose of the study was to investigate the efficacy of Mastodynon® in terms of indications in elevated doses versus the standard dose. Materials and methods. Data were analyzed for 60 patients after surgical treatment of fibrocystic mastopathy
Externí odkaz:
https://doaj.org/article/b2fafbf0e224486eb4fb991434857ffb
Publikováno v:
Репродуктивная эндокринология, Iss 41, Pp 73-76 (2018)
The article presents a systematic review of the main pathogenetic mechanisms of the onset and development of insufficiency of the luteal phase (ILF) and its association with hypothalamic-pituitary-ovarian dysfunction. The characteristics of clinical
Externí odkaz:
https://doaj.org/article/d552e1e10b6a4f82850827e1b14a4edb
Autor:
И. В. Высоцкая, В. П. Летягин
Publikováno v:
Репродуктивная эндокринология, Iss 40, Pp 93-97 (2018)
Dyshormonal breast dysplasia is the most frequent pathology encountered by practitioners. The interest of clinicians to these processes is associated with several factors. On the one hand effective treatment, relieves symptoms, ensures the quality of
Externí odkaz:
https://doaj.org/article/a0c0d532b6e24dddac1b0de3be1c0e2b
Autor:
В. Н. Прилепская, Э. Р. Довлетханова
Publikováno v:
Репродуктивная эндокринология, Iss 39, Pp 76-80 (2018)
The premenstrual syndrome (PMS) is a pathological symptom that significantly reduces the quality of a woman’s life. The etiology and pathogenesis to date have not been sufficiently studied, but the diagnosis, treatment and prevention that are to be
Externí odkaz:
https://doaj.org/article/77a3642b23e64a1a8998f706b14f90fd
Autor:
Н. В. Кулагина
Publikováno v:
Репродуктивная эндокринология, Iss 38, Pp 81-85 (2017)
Objective. To evaluate the efficacy and tolerability of Mastodynon® in the treatment of diffuse mastopathy and symptoms of premenstrual syndrome (PMS) in women in the menopausal transition period. Subjects and methods. A clinical prospective, para
Externí odkaz:
https://doaj.org/article/37a3f6a3af024f3098bf398bb44424b7